Neri, B <br/><br/>
Gemcitabine plus Epi-doxorubicin as first-line chemotherapy for bladder cancer in advanced or metastatic stage: a phase II.  [electronic resource] 

 -  Anticancer research   
 - 2981-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Deoxycytidine--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Urinary Bladder Neoplasms--drug therapy<br/>Gemcitabine